Kan Xue

659 total citations
30 papers, 458 citations indexed

About

Kan Xue is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Kan Xue has authored 30 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 12 papers in Gastroenterology and 10 papers in Surgery. Recurrent topics in Kan Xue's work include Gastric Cancer Management and Outcomes (23 papers), Metastasis and carcinoma case studies (14 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). Kan Xue is often cited by papers focused on Gastric Cancer Management and Outcomes (23 papers), Metastasis and carcinoma case studies (14 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). Kan Xue collaborates with scholars based in China, Ethiopia and United States. Kan Xue's co-authors include Jiafu Ji, Yongning Jia, Ziyu Li, Fei Shan, Rulin Miao, Yinkui Wang, Li Z, Andrew J. Sanders, Malcolm Mason and Wen G. Jiang and has published in prestigious journals such as PLoS ONE, Chemical Engineering Journal and Applied Surface Science.

In The Last Decade

Kan Xue

27 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kan Xue China 10 236 147 124 110 98 30 458
Dejun Zhou China 12 148 0.6× 117 0.8× 140 1.1× 49 0.4× 107 1.1× 39 391
Eri Munekage Japan 12 159 0.7× 37 0.3× 131 1.1× 65 0.6× 136 1.4× 36 376
Shuntai Chen China 10 205 0.9× 161 1.1× 174 1.4× 24 0.2× 186 1.9× 22 512
Shaoliang Han China 12 82 0.3× 104 0.7× 108 0.9× 92 0.8× 129 1.3× 28 344
Mitsuhiro Miyazaki Japan 13 137 0.6× 156 1.1× 140 1.1× 28 0.3× 100 1.0× 22 397
Wenying Deng China 11 116 0.5× 168 1.1× 82 0.7× 34 0.3× 123 1.3× 34 372
M. Robaszkiewicz France 9 95 0.4× 95 0.6× 123 1.0× 41 0.4× 77 0.8× 40 297
Zakaria Eltahir United Kingdom 9 375 1.6× 143 1.0× 353 2.8× 169 1.5× 309 3.2× 12 745
Leo Taniguchi Japan 7 94 0.4× 184 1.3× 171 1.4× 121 1.1× 154 1.6× 11 428
Dazhou Li China 11 139 0.6× 136 0.9× 136 1.1× 56 0.5× 80 0.8× 49 373

Countries citing papers authored by Kan Xue

Since Specialization
Citations

This map shows the geographic impact of Kan Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kan Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kan Xue more than expected).

Fields of papers citing papers by Kan Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kan Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kan Xue. The network helps show where Kan Xue may publish in the future.

Co-authorship network of co-authors of Kan Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Kan Xue. A scholar is included among the top collaborators of Kan Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kan Xue. Kan Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yinkui, Fei Shan, Shuangxi Li, et al.. (2025). Identifying potential beneficiaries of neoadjuvant therapy in borrmann type III and IV gastric cancer: A treatment heterogeneity analysis using causal survival forests. European Journal of Surgical Oncology. 51(8). 109752–109752.
2.
Ye, Zixuan, Yanan Li, Xia Luo, et al.. (2025). In situ gels for postoperative cancer treatment: Current status and challenges. Chemical Engineering Journal. 505. 159621–159621. 2 indexed citations
3.
Xue, Kan, Hang Chen, Biao He, et al.. (2025). High-performance and enhanced electromagnetic wave absorption of hydrothermal SnS2/rGO composites in 2–18 GHz. Applied Surface Science. 688. 162462–162462. 3 indexed citations
6.
Wang, Yinkui, Fei Shan, Shuangxi Li, et al.. (2023). Efficacy and safety of preoperative immunotherapy alone followed by surgery in the treatment of advanced gastric cancer with MSI-H/dMMR or EBV-positive. Journal of the Chinese Medical Association. 86(8). 717–724. 7 indexed citations
7.
Xue, Kan, et al.. (2023). Combined Efficacy of Pregabalin and Suspension System in Lumbar Disc Herniation and its Impact on JOA and ODI Score. Indian Journal of Pharmaceutical Sciences. 85(S5).
8.
Li, Bailong, Rulin Miao, Fei Shan, et al.. (2023). Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology. World Journal of Surgical Oncology. 21(1). 204–204. 5 indexed citations
9.
Shan, Fei, Shuangxi Li, Yongning Jia, et al.. (2022). The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer. Frontiers in Oncology. 12. 956706–956706. 1 indexed citations
10.
Wang, Yinkui, Fei Shan, Shuangxi Li, et al.. (2022). Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer: a systematic review and meta-analysis of randomized controlled trials. World Journal of Surgical Oncology. 20(1). 405–405. 12 indexed citations
11.
Wang, Yinkui, Fei Shan, Shuangxi Li, et al.. (2022). Safety and short-term outcomes of gastrectomy after preoperative chemotherapy plus immunotherapy versus preoperative chemotherapy: a retrospective cohort study. BMC Cancer. 22(1). 1306–1306. 6 indexed citations
13.
Liu, Zining, Yinkui Wang, Fei Shan, et al.. (2021). Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved. Frontiers in Oncology. 11. 775166–775166. 3 indexed citations
14.
Wang, Yinkui, Ziyu Li, Fei Shan, et al.. (2018). [Current status of diagnosis and treatment of early gastric cancer in China--Data from China Gastrointestinal Cancer Surgery Union].. PubMed. 21(2). 168–174. 26 indexed citations
18.
Ye, Lin, Yongning Jia, Ke Ji, et al.. (2015). Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis. Oncology Letters. 10(3). 1240–1250. 124 indexed citations
19.
Shan, Fei, Rulin Miao, Kan Xue, et al.. (2015). Controlling angiogenesis in gastric cancer: A systematic review of anti-angiogenic trials. Cancer Letters. 380(2). 598–607. 23 indexed citations
20.
Sakoda, Lori C., Kan Xue, Jennifer A. Doherty, et al.. (2007). Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women. Breast Cancer Research and Treatment. 109(1). 143–155. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026